Publicaciones en colaboración con investigadores/as de University of Western Australia (11)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts

    JAMA Oncology, Vol. 8, Núm. 3

  2. Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

    The Lancet Oncology, Vol. 23, Núm. 8, pp. 1055-1065

  3. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2020

  1. DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies

    Genome Medicine, Vol. 12, Núm. 1

  2. Engineering a humanised niche to support human haematopoiesis in mice: novel opportunities in modelling cancer

    Cancers, Vol. 12, Núm. 8, pp. 1-23

2019

  1. Epigenome-wide meta-analysis of DNA methylation and childhood asthma

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 6, pp. 2062-2074

2017

  1. Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium

    Human Molecular Genetics, Vol. 26, Núm. 20, pp. 4067-4085

2016

  1. SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer

    Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731

2014

  1. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: The SIRFLOX study

    BMC Cancer, Vol. 14, Núm. 1